As the Biden administration’s marijuana scheduling review continues, the head of the U.S. Department of Health and Human Services (HHS) says his agency is uniquely positioned to “update the science” to ensure that drugs are “properly” classified under federal law. During a hearing before the Senate Appropriations Committee on Wednesday, Sen. Martin Heinrich (D-NM) asked … Continue reading Top Federal Health Official Touts Science-Based Drug Scheduling Process Amid Marijuana Review